Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Other physiological choline transporters" refers to a group of proteins, primarily the Solute Carrier Family 44 (SLC44A1-5), that facilitate the sodium-independent, intermediate-affinity uptake of choline across cell membranes (IUPHAR/BGP). Unlike the high-affinity choline transporter (CHT1) which is restricted to cholinergic neurons, these transporters are widely expressed throughout the body and are essential for the synthesis of phosphatidylcholine, the most abundant phospholipid in eukaryotic membranes (UniProt P58196). SLC44A1 (CTL1) is ubiquitously expressed and plays a critical role in cellular lipid metabolism and mitochondrial function, while SLC44A2 (CTL2) is highly expressed in the inner ear and has been identified as a major autoantigen in autoimmune hearing loss (UniProt Q8IWA5). These transporters are increasingly recognized as therapeutic targets in oncology because rapidly proliferating cancer cells upregulate choline uptake to support accelerated membrane synthesis (Inazu, 2014). While they are inhibited by classical compounds like hemicholinium-3, their broad physiological distribution poses significant challenges for achieving tissue-specific therapeutic effects without systemic toxicity (Traiffort et al., 2013).
Inhibition of sodium-independent choline uptake to deplete intracellular choline stores, thereby disrupting phospholipid synthesis and inducing apoptosis in rapidly dividing cells.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Other physiological choline transporters.